Is metformin still the most efficacious first‐line oral hypoglycaemic drug in treating type 2 diabetes? A network meta‐analysis of randomized controlled trials

The objective of the study is to compare the efficacy of hypoglycaemic drugs for type 2 diabetes mellitus (T2DM) by network meta‐analysis of randomized controlled trials (RCTs).

• Publication year

  2018

• Venue

  Obesity Reviews

• Publication date

  2018-09-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/obr.12753PMID 30230172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fixed and Random-Effects Models for Meta-Analysis

  2021cited by this paper
• Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes

  2020cited by this paper
• Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise

  2020cited by this paper
• Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis

  2020cited by this paper
• Metformin

  2019cited by this paper
• Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy

  2019cited by this paper
• MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus

  2019cited by this paper
• Using decision thresholds for ranking treatments in network meta-analysis results in more informative rankings.

  2018cited by this paper
• Management of diabetes in older adults.

  2017cited by this paper
• Approaches to interpreting and choosing the best treatments in network meta-analyses

  2017cited by this paper
• Metformin; a review of its history and future: from lilac to longevity

  2017cited by this paper
• Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea

  2016cited by this paper
• Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers

  2016cited by this paper
• Metformin in type 2 diabetes: where is the evidence?

  2016cited by this paper
• Metformin as firstline treatment for type 2 diabetes: are we sure?

  2016cited by this paper
• Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology

  2015cited by this paper
• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

  2015cited by this paper
• Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis

  2015cited by this paper
• Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis

  2015cited by this paper
• Triple therapy in type 2 diabetes; a systematic review and network meta-analysis

  2015cited by this paper
• Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options

  2014cited by this paper
• Dapagliflozin compared with other oral anti‐diabetes treatments when added to metformin monotherapy: a systematic review and network meta‐analysis

  2014cited by this paper
• Diabetes Management in Clinical Practice

  2014cited by this paper
• Metformin Pharmacogenomics: Current Status and Future Directions

  2014cited by this paper
• Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Current Status and Future Directions

  2013cited by this paper
• Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis

  2013cited by this paper
• A Bayesian Network Meta-analysis for Binary Outcome : A Simulation Study

  2013cited by this paper
• Standards of Medical Care in Diabetes—2014

  2013cited by this paper
• The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus

  2013cited by this paper
• Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation

  2013cited by this paper
• The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration

  2013cited by this paper
• Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta‐analysis

  2012cited by this paper
• Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients

  2012cited by this paper
• Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control

  2012cited by this paper
• Cellular and molecular mechanisms of metformin: an overview.

  2012cited by this paper
• New Mechanisms in Glucose Control: Barnett/New Mechanisms in Glucose Control

  2011cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

  2011cited by this paper
• Effect of Antihyperglycemic Agents Added to Metformin and a Sulfonylurea on Glycemic Control and Weight Gain in Type 2 Diabetes: A Network Meta-analysis

  2011cited by this paper
• A basic introduction to fixed‐effect and random‐effects models for meta‐analysis

  2010cited by this paper
• Methods Guide for Comparative Effectiveness Reviews Identifying , Selecting , and Refining Topics

  2009cited by this paper
• Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

  2008cited by this paper
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

  2008cited by this paper
• Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

  2005cited by this paper
• Combination of direct and indirect evidence in mixed treatment comparisons

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.

  2002cited by this paper
• Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.

  2002cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility

  2000cited by this paper
• Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes.

  1999cited by this paper
• Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.

  1998cited by this paper
• Prognosis of acute myocardial infarction in relation to age

  1990cited by this paper

• Natural polymers in diabetes management: formulation prospects of Hibiscus rosa-sinensis mucilage for metformin sustained release

  2026cites this paper
• Effects of different hypoglycaemic drugs on beta-cell function in type 2 diabetes mellitus: a systematic review and network meta-analysis

  2025cites this paper
• Metformin as a potential neuroprotective agent that influence Parkinson’s disease

  2025cites this paper
• Metformin’s Overall Effectiveness and Combined Action with Lifestyle Interventions in Preventing Type-2 Diabetes Mellitus in High-Risk Metformin-Naïve Patients: An Updated Systematic Review and Meta-Analysis of Published RCTs

  2025cites this paper
• Screening of Lactococcus lactis strains with hypoglycemic effects and evaluation of their protective mechanisms against glucose-induced type 2 diabetes in zebrafish.

  2025cites this paper
• Effect of Coenzyme Q10 Supplementation on Lipid and Glycaemic Profiles: An Umbrella Review

  2024influential citation
• Machine learning algorithms mimicking specialists decision making on initial treatment for people with type 2 diabetes mellitus in Japan diabetes data management study (JDDM76).

  2024cites this paper
• Advances in small-molecule insulin secretagogues for diabetes treatment.

  2024cites this paper
• Metformin ameliorates insulin resistance, thyroid nodules and thyroid function.

  2023cites this paper
• Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review.

  2023cites this paper
• Clinical Effects of Exercise Rehabilitation Combined with Repaglinide in the Treatment of Diabetes

  2022cites this paper
• NARRATIVE REVIEW: COST-EFFECTIVENESS ANALYSIS OF BIGUANIDE AND SULFONYLUREA FOR HOSPITALIZED PATIENT WITH TYPE 2 DIABETES MELLITUS

  2022cites this paper
• How efficacious are traditional Chinese medicine injections in treating angina pectoris? A network meta-analysis of randomized controlled trials.

  2022cites this paper
• The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan.

  2022cites this paper
• Mechanisms of Metformin Improving vasodilation of coronary artery in Type 2 Diabetic Rats

  2022cites this paper
• Ameliorative and Antioxidative Potential of Lactobacillus plantarum-Fermented Oat (Avena sativa) and Fermented Oat Supplemented with Sidr Honey against Streptozotocin-Induced Type 2 Diabetes in Rats

  2022cites this paper
• The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study

  2022cites this paper
• First‐line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs

  2021cites this paper
• Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease

  2021cites this paper
• Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas

  2021cites this paper
• Lipidomics characterization of the mechanism of Cynomorium songaricum polysaccharide on treating type 2 diabetes.

  2021cites this paper
• Metformin, Macrophage Dysfunction and Atherosclerosis

  2021cites this paper
• Metformin-Loaded Polymer-Based Microbubbles/Nanoparticles Generated for the Treatment of Type 2 Diabetes Mellitus.

  2021cites this paper
• Effect of Lactobacillus fermentum TKSN041 on improving streptozotocin-induced type 2 diabetes in rats.

  2021cites this paper
• Effect and Safety of Acupuncture for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of 21 Randomised Controlled Trials

  2021cites this paper
• Prescription pattern and cost variation analysis in type 2 diabetes mellitus patients at private outpatient department

  2021cites this paper
• Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis

  2021cites this paper
• Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges

  2021cites this paper
• Histological and Immunohistochemical Study on the Effect of the Combined Vitamin C and Metformin versus Metformin Alone in Treating Diabetic Myopathy in Rat

  2021cites this paper
• Research Progress of Herbal Medicines on Drug Metabolizing Enzymes: Consideration Based on Toxicology.

  2020cites this paper
• Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis

  2020cites this paper
• Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise

  2020cites this paper
• Dietary habits and metabolic response improve in obese children whose mothers received an intervention to promote healthy eating: randomized clinical trial

  2020cites this paper
• Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats.

  2020cites this paper
• Association between neighborhood aesthetics and childhood obesity

  2020cites this paper
• Neighborhood sidewalk access and childhood obesity

  2020cites this paper
• Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes

  2020cites this paper
• Pharmacological modulation of the hydrogen sulfide (H2S) system by dietary H2S‐donors: A novel promising strategy in the prevention and treatment of type 2 diabetes mellitus

  2020cites this paper
• Suppression of type 2 diabetes mellitus-induced aortic ultrastructural alterations in rats by insulin: an association of vascular injury biomarkers

  2020influential citation
• Associations between taste preferences and chronic diseases: a population-based exploratory study in China

  2020cites this paper
• CCID_A_243154 197..207

  2020cites this paper
• The synergistic effect of fenretinide and metformin to achieve a decrease in insulin resistance and inflammatory mediators: an in vivo study

  2020cites this paper
• Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes

  2020cites this paper
• MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus

  2019cites this paper
• Gestational diabetes mellitus

  2019cites this paper
• Diabesity and antidiabetic drugs.

  2019cites this paper
• Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy

  2019cites this paper
• Progress Evaluation for Transnational Restaurant Chains to Reformulate Products and Standardize Portions to Meet Healthy Dietary Guidelines and Reduce Obesity and Non-Communicable Disease Risks, 2000–2018: A Scoping and Systematic Review to Inform Policy

  2019cites this paper